1 articles · Updated · Zacks Investment Research · Jun 22
Summary
Centene, DaVita and BrightSpring extended strong 2026 gains as investors rotated into healthcare names amid broader post-SpaceX IPO optimism and expectations for a stronger second half.
SpaceX’s $75 billion debut has helped lift sentiment across equities—the S&P 500 is up nearly 1.5% since the June 11 listing—while index additions and a 37% post-IPO rise keep risk appetite elevated.
Centene has climbed 48.3% this year, with improving Medicaid margins and raised 2026 EPS guidance supporting an earnings-growth estimate of 66.8% despite a projected 1.9% sales decline.
DaVita is up 83% year to date and BrightSpring 76.9%, backed by higher dialysis volumes, kidney-care expansion, specialty pharmacy growth and home-health demand; both also carry upgraded 2026 earnings outlooks.
Healthcare’s broader setup remains supportive: the sector is down 5.8% this year, trades at 19.77 times forward earnings versus a 20.45 five-year median, and is drawing bullish calls tied to AI adoption and demographic demand.
With tech stocks soaring, is the undervalued healthcare sector the market’s next safe bet for significant growth?
As AI giants like Anthropic go public, what are the hidden risks of their world-changing technologies?
The Iran peace deal promises cheaper oil, but what are the overlooked economic ripple effects for global trade?
SpaceX’s $75 Billion IPO Sets New Market Benchmark: Starlink, xAI, and the Future of Tech Investing
Overview
SpaceX made its public debut on June 12, 2026, marking a significant event in financial markets and setting a new benchmark for IPOs. The company’s extensive marketing efforts, led by Gwynne Shotwell and Bret Johnsen, attracted sizable orders from long-term investors, showing strong institutional confidence in SpaceX’s future. This immense investor interest signaled a bullish outlook for space exploration and satellite internet services. The IPO’s success reflected not only the company’s innovative vision but also growing enthusiasm for high-growth, technology-driven ventures, positioning SpaceX as a leader in the new era of market opportunities.